GREY:FEBTF - Post by User
Comment by
europe10on Oct 20, 2011 4:51am
288 Views
Post# 19165798
RE: Novozyme
RE: NovozymeHi Skyhi,
I fully share your frustration with FEB.
However, to compare with Novozymes is not really that interesting.
They have a market cap of over 8 bio USD, and are market leaders in enzymes.
And have been for many years.
I have no figures of their sales of enzymes in the FEB potential market place, but if they have any sales they are miniscule compared to the size of this company.
Enzymes do work, but apperently better in the lab than in the real production chain.
Also - enzymes are very very expensive to use for the potential clients.
If FEB yeasts work in the real life -- Novozymes can forget about this market niche.
Back to FEB,
If invested in this stock - that I unfortunately am, extreme long time horizon is a must.
And a capability of taking a full loss of the investment.
I cannot judge if they have a 10, 20% or mabe even 30% chance of success. But the reward will be significant if they do. I am not talking 5 times the money, but much larger numbers.
As they have not managed to close contracts to date, I fear that the odds are not very good.
And the risk of further diluting financing is growing day by day.